- Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
-
Kim MK, Seong SJ
- KMID: 2130092
- J Gynecol Oncol.
- 2014 Jul;25(3):164-165.
- doi: 10.3802/jgo.2014.25.3.164
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
-
Shan W, Wang C, Zhang Z, Gu C, Ning C, Luo X, Zhou Q, Chen X
- KMID: 2130102
- J Gynecol Oncol.
- 2014 Jul;25(3):214-220.
- doi: 10.3802/jgo.2014.25.3.214
OBJECTIVE: To compare the efficacy of metformin plus megestrol acetate (MA) with that of MA alone for treating endometrial atypical hyperplasia (EAH). METHODS: This pilot study included 16 EAH patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
-
Hong S, Jeong IG, You D, Lee JL, Hong JH, Ahn H, Kim CS
- KMID: 1777555
- J Korean Med Sci.
- 2013 May;28(5):687-692.
- doi: 10.3346/jkms.2013.28.5.687
There are concerns whether megestrol acetate (MA) stimulates the growth of prostate cancer in castration-resistant prostate cancer (CRPC). We evaluated the effect of cumulative doses of MA on the disease-specific... -
- CITED
-
- Close
- SHARE
-
- Close
